GLPG Galapagos NV

Galapagos to present at upcoming investor conferences

Galapagos to present at upcoming investor conferences

Mechelen, Belgium; 24 August 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that management will participate in the following upcoming investor conferences: 

  • Citi’s 17th Annual Biopharma Conference. September 8, 2022 in Boston
  • Morgan Stanley 20th Global Healthcare Conference. September 12-14, 2022 in New York
  • Bank of America Merrill Lynch Global Healthcare Conference. September 15, 2022 in London
  • KBC Securities Virtual Life Sciences Conference. September 16, 2022
  • JP Morgan CEO Call Series. September 28, 2022
  • Credit Suisse 31st Annual Healthcare Conference. November 8-10, 2022 in Rancho Palos Verdes, CA
  • Bryan Garnier Virtual Conference on Cell Therapy Innovation. November 14, 2022
  • Jefferies 2022 Global Healthcare Conference. November 16-17, 2022 in London
  • Kepler Cheuvreux Virtual Life Science Days. November 21, 2022
  • Deutsche Bank 2022 Call Series. November 30, 2022



Additional information regarding these events will be available on the investor section of the Galapagos website at .

About Galapagos

Galapagos is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 3 programs in inflammation, oncology, fibrosis, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is approved and available in the European Union (including Norway), Great Britain and Japan. For additional information, please visit or follow us on or .

Contact

Investors:

Sofie Van Gijsel

Head of Investor Relations

Sandra Cauwenberghs

Director Investor Relations

3

Media:

Marieke Vermeersch

Head of Corporate Communication



Forward-looking statements

This release may contain forward-looking statements. Such forward-looking statements are not guarantees of future results. These forward-looking statements speak only as of the date of publication of this document. Galapagos expressly disclaims any obligation to update any forward-looking statements in this document, unless specifically required by law or regulation.

 

Attachment



EN
24/08/2022

Underlying

GLPGGalapagos NV

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Galapagos NV

Hilde Van Boxstael ... (+5)
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Mathijs Geerts Danau
  • Wim Hoste
  • Wim Lewi
COFB COFINIMMO SA
GLPG GALAPAGOS NV
UMI UMICORE
02/20/26 February 20, 2026 1 EN
 PRESS RELEASE
Free
GLPG GALAPAGOS NV

Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors  

Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors   Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board Mechelen, Belgium; February 19, 2026, 22:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced the appointment by way of co-optation of Dr. Paulo Fontoura as Non-Executive Independent Director to its Board of Directors, effective February 9, 2026. “We are pleased to welcome Paulo to our Board,” said Jérôme Contamine, Chair of the Board of Galapagos. “His global leadership experience, deep understanding ...

February 19, 2026 1 EN
 PRESS RELEASE
Free
GLPG GALAPAGOS NV

Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur  

Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur   Dr. Fontoura brengt uitgebreide ervaring in wereldwijd leiderschap, klinische ontwikkeling en operationele aansturing mee naar de Raad van Bestuur Mechelen, België; 19 februari 2026, 22:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG) kondigde vandaag de benoeming aan, via coöptatie, van Dr. Paulo Fontoura als Niet-Uitvoerend Onafhankelijk Bestuurder in haar Raad van Bestuur, met ingang van 9 februari 2026. “We zijn verheugd Paulo te verwelkomen in onze Raad van Bestuur”, aldus Jérôme Contamine, Voorzitter van de Raad van ...

February 19, 2026 1 EN
 PRESS RELEASE
Free
GLPG GALAPAGOS NV

Galapagos Receives Transparency Notification from Bank of America

Galapagos Receives Transparency Notification from Bank of America Mechelen, Belgium; February 16, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America. Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on February 11, 2026, from Bank of America Corporation. The notification indicates that Bank of America Corporation, as controlling entity, crossed above the threshold of 5% of Galapagos’ voting rights on February 9, 2026, including the threshold of 5% for equival...

February 16, 2026 1 EN
 PRESS RELEASE
Free
GLPG GALAPAGOS NV

Galapagos ontvangt transparantieverklaring van Bank of America

Galapagos ontvangt transparantieverklaring van Bank of America Mechelen, België; 16 februari 2026, 22:01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) heeft een transparantieverklaring ontvangen van Bank of America. Overeenkomstig de Belgische transparantiewetgeving1 ontving Galapagos op 11 februari 2026 een transparantieverklaring van Bank of America Corporation. Daaruit blijkt dat Bank of America Corporation, als controlerende entiteit, op 9 februari 2026 de drempel van 5% van de stemrechten van Galapagos heeft overschreden, met inbegrip van de drempel van 5%...

February 16, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch